These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2688649)

  • 1. Enhancement of butyrate-induced differentiation of HT-29 human colon carcinoma cells by 1,25-dihydroxyvitamin D3.
    Tanaka Y; Bush KK; Klauck TM; Higgins PJ
    Biochem Pharmacol; 1989 Nov; 38(21):3859-65. PubMed ID: 2688649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 1,25-dihydroxyvitamin D3 and its analogs on butyrate-induced differentiation of HT-29 human colonic carcinoma cells and on the reversal of the differentiated phenotype.
    Tanaka Y; Bush KK; Eguchi T; Ikekawa N; Taguchi T; Kobayashi Y; Higgins PJ
    Arch Biochem Biophys; 1990 Feb; 276(2):415-23. PubMed ID: 2306105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of plasminogen activator inhibitor type 1 (PAI-1) by HT-29di human large bowel carcinoma cells is modulated as a function of epithelial differentiation.
    Higgins PJ; Lipkin M
    Cancer Lett; 1994 Jan; 76(2-3):167-75. PubMed ID: 8149346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-chain fatty acids and colon cancer cells: the vitamin D receptor--butyrate connection.
    Gaschott T; Stein J
    Recent Results Cancer Res; 2003; 164():247-57. PubMed ID: 12899527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hexafluoro-1,25-dihydroxyvitamin D3 and sodium butyrate combination on differentiation and proliferation of HL-60 leukemia cells.
    Yoshida M; Tanaka Y; Eguchi T; Ikekawa N; Saijo N
    Anticancer Res; 1992; 12(6B):1947-52. PubMed ID: 1363510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium butyrate (SB) augments the effects of 1,25 dihydroxyvitamin D3 (1,25(OH)2D3) on neoplastic and osteoblastic phenotype in clonal rat osteosarcoma cells.
    Yoneda T; Aya S; Sakuda M
    Biochem Biophys Res Commun; 1984 Jun; 121(3):796-801. PubMed ID: 6588971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 1,25-dihydroxyvitamin D3 on proliferation and differentiation of Caco-2 cells.
    Halline AG; Davidson NO; Skarosi SF; Sitrin MD; Tietze C; Alpers DH; Brasitus TA
    Endocrinology; 1994 Apr; 134(4):1710-7. PubMed ID: 8137734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3.
    Shabahang M; Buras RR; Davoodi F; Schumaker LM; Nauta RJ; Uskokovic MR; Brenner RV; Evans SR
    Cancer Res; 1994 Aug; 54(15):4057-64. PubMed ID: 8033137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptors for and bioresponses to 1,25-dihydroxyvitamin D in a human colon carcinoma cell line (HT-29).
    Harper KD; Iozzo RV; Haddad JG
    Metabolism; 1989 Nov; 38(11):1062-9. PubMed ID: 2554092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cell surface EGF receptor expression during the butyrate-induced differentiation of human HCT-116 colon tumor cell clones.
    Nathan DF; Burkhart SR; Morin MJ
    Exp Cell Res; 1990 Sep; 190(1):76-84. PubMed ID: 1974861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells.
    Zhao X; Feldman D
    Endocrinology; 1993 Apr; 132(4):1808-14. PubMed ID: 8384998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butyrate-induced alterations of phosphoinositide metabolism, protein kinase C activity and reduced CD44 variant expression in HT-29 colon cancer cells.
    Kopp R; Fichter M; Assert R; Pfeiffer AF; Classen S
    Int J Mol Med; 2009 May; 23(5):639-49. PubMed ID: 19360323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of extracellular calcium on colonocytes: evidence for differential responsiveness based upon degree of cell differentiation.
    Buras RR; Shabahang M; Davoodi F; Schumaker LM; Cullen KJ; Byers S; Nauta RJ; Evans SR
    Cell Prolif; 1995 Apr; 28(4):245-62. PubMed ID: 7772641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium butyrate alters the response of a human colon carcinoma cell line to transforming growth factor-beta 1.
    Lewis LR; Levine AE
    Cancer Lett; 1992 Mar; 63(1):33-40. PubMed ID: 1555205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates.
    Yang GY; Shamsuddin AM
    Anticancer Res; 1995; 15(6B):2479-87. PubMed ID: 8669811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in telomerase activity, expression and splicing in response to differentiation of normal and carcinoma colon cells.
    Fajkus J; Borsky M; Kunická Z; Kovaríková M; Dvoráková D; Hofmanová J; Kozubík A
    Anticancer Res; 2003; 23(2B):1605-12. PubMed ID: 12820429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
    Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of resting zone chondrocytes with 24,25-dihydroxyvitamin D3 [24,25-(OH)2D3] induces differentiation into a 1,25-(OH)2D3-responsive phenotype characteristic of growth zone chondrocytes.
    Schwartz Z; Dean DD; Walton JK; Brooks BP; Boyan BD
    Endocrinology; 1995 Feb; 136(2):402-11. PubMed ID: 7530645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.
    Hinnebusch BF; Meng S; Wu JT; Archer SY; Hodin RA
    J Nutr; 2002 May; 132(5):1012-7. PubMed ID: 11983830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of type I collagen on the growth and differentiation of the human colonic adenocarcinoma cell line HT-29 in vitro.
    East JA; Langdon SP; Townsend KM; Hickman JA
    Differentiation; 1992 Aug; 50(3):179-88. PubMed ID: 1426702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.